Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey

The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not...

Descripción completa

Detalles Bibliográficos
Autores: Hoste, Levi, Soriano-Arandes, Antoni, Buddingh, Emilie Pauline, Whittaker, Elizabeth, Belot, Alexandre, Ulloa-Gutiérrez, Rolando, Olbrich, Peter, Haerynck, Filomeen
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2022
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/166982
Acceso en línea:https://hdl.handle.net/11441/166982
https://doi.org/10.1016/j.jpeds.2022.05.028
Access Level:acceso abierto
Palabra clave:COVID-19
MIS-C
SARS-CoV-2
Adverse Events
Vaccination
id ES_fe3fd991ff8d0175a6dd59bcecfbe4ab
oai_identifier_str oai:idus.us.es:11441/166982
network_acronym_str ES
network_name_str España
repository_id_str
spelling Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international surveyHoste, LeviSoriano-Arandes, AntoniBuddingh, Emilie PaulineWhittaker, ElizabethBelot, AlexandreUlloa-Gutiérrez, RolandoOlbrich, PeterHaerynck, FilomeenCOVID-19MIS-CSARS-CoV-2Adverse EventsVaccinationThe optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.ElsevierFarmacología, Pediatría y Radiología2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/166982https://doi.org/10.1016/j.jpeds.2022.05.028reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésJournal of pediatrics, 28, 114-118.https://www.jpeds.com/article/S0022-3476(22)00438-3/fulltextinfo:eu-repo/semantics/openAccessoai:idus.us.es:11441/1669822026-06-17T12:51:07Z
dc.title.none.fl_str_mv Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
title Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
spellingShingle Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
Hoste, Levi
COVID-19
MIS-C
SARS-CoV-2
Adverse Events
Vaccination
title_short Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
title_full Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
title_fullStr Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
title_full_unstemmed Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
title_sort Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey
dc.creator.none.fl_str_mv Hoste, Levi
Soriano-Arandes, Antoni
Buddingh, Emilie Pauline
Whittaker, Elizabeth
Belot, Alexandre
Ulloa-Gutiérrez, Rolando
Olbrich, Peter
Haerynck, Filomeen
author Hoste, Levi
author_facet Hoste, Levi
Soriano-Arandes, Antoni
Buddingh, Emilie Pauline
Whittaker, Elizabeth
Belot, Alexandre
Ulloa-Gutiérrez, Rolando
Olbrich, Peter
Haerynck, Filomeen
author_role author
author2 Soriano-Arandes, Antoni
Buddingh, Emilie Pauline
Whittaker, Elizabeth
Belot, Alexandre
Ulloa-Gutiérrez, Rolando
Olbrich, Peter
Haerynck, Filomeen
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Farmacología, Pediatría y Radiología
dc.subject.none.fl_str_mv COVID-19
MIS-C
SARS-CoV-2
Adverse Events
Vaccination
topic COVID-19
MIS-C
SARS-CoV-2
Adverse Events
Vaccination
description The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/166982
https://doi.org/10.1016/j.jpeds.2022.05.028
url https://hdl.handle.net/11441/166982
https://doi.org/10.1016/j.jpeds.2022.05.028
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Journal of pediatrics, 28, 114-118.
https://www.jpeds.com/article/S0022-3476(22)00438-3/fulltext
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425667432513536
score 15.812455

Similares en LA Referencia